530317 — Godavari Drugs Cashflow Statement
0.000.00%
- IN₹1.32bn
- IN₹1.99bn
- IN₹1.06bn
Annual cashflow statement for Godavari Drugs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 116 | 108 | 138 | 128 | 115 |
| Deferred Taxes | |||||
| Non-Cash Items | -2.76 | -6.55 | -6.17 | -9.77 | -8.05 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 4.88 | 32 | 52 | -6.32 | -99.4 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 112 | 132 | 184 | 112 | 7.34 |
| Capital Expenditures | -52.5 | -93 | -132 | -200 | -267 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 2.74 | 6.58 | -0.202 | 4.86 | 7.75 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -49.7 | -86.4 | -132 | -195 | -259 |
| Financing Cash Flow Items | -29.1 | -39.4 | -48.7 | -46.6 | 164 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -56.2 | -37.7 | -56.5 | 80.7 | 374 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 6.38 | 8.08 | -4.62 | -2.5 | 121 |